Professional Overview
Larry Madison is an accomplished financial planning and analysis executive with extensive experience in the pharmaceutical and real estate industries. As the Vice President of Financial Planning and Analysis at Meitheal Pharmaceuticals, Inc., he leverages his expertise in financial modeling, forecasting, and strategic decision support to drive business growth and profitability.
Experience Summary
Current Role
As the Vice President of Financial Planning and Analysis at Meitheal Pharmaceuticals, Inc., Larry oversees the company's financial planning, budgeting, and forecasting processes. He collaborates closely with cross-functional teams to provide valuable insights and recommendations that inform strategic decision-making. Under his leadership, the financial planning and analysis team has played a pivotal role in supporting Meitheal's successful expansion into new therapeutic areas and international markets.
Career Progression
Prior to his current role, Larry held senior financial positions at Xellia Pharmaceuticals, Sagent Pharmaceuticals, McGraw-Hill Higher Education, and Pasquinelli Homes. Throughout his career, he has consistently demonstrated a talent for identifying cost-saving opportunities, optimizing resource allocation, and aligning financial strategies with broader business objectives. His proven track record of driving continuous improvement and delivering measurable financial results has earned him a reputation as a trusted strategic partner.
Academic Background
Larry holds a Bachelor of Science in Finance from the University of Illinois at Urbana-Champaign, where he graduated cum laude. He has also completed executive education programs in strategic financial management and advanced data analytics, enhancing his ability to leverage data-driven insights to drive organizational success.
Areas of Expertise
- Financial planning, budgeting, and forecasting
- Financial modeling and data analysis
- Strategic business partnering and decision support
- Cost optimization and resource allocation
- Financial reporting and performance management
- Cross-functional collaboration and stakeholder management
Professional Impact
Throughout his career, Larry has played a pivotal role in shaping the financial strategies of leading pharmaceutical and real estate companies. At Meitheal Pharmaceuticals, he has been instrumental in securing funding for major research and development initiatives, enabling the company to bring innovative therapies to market. Additionally, his expertise in financial planning and analysis has been critical in driving operational efficiencies and improving profitability across the organization.
Conclusion
With his deep industry knowledge, financial acumen, and strategic leadership, Larry Madison is poised to continue making a significant impact in the pharmaceutical industry. As Meitheal Pharmaceuticals' Vice President of Financial Planning and Analysis, he is dedicated to leveraging data-driven insights to support the company's long-term growth and sustainability.
